PHARMA SOLUTION
https://pharmasolutionsindia.in/ ✍️A PROFESSIONAL PHARMA ONLINE SERVICE ✅ 🏆🏆 FOR PHARMACIST 🏆🏆 ✅ PHARMA COMPETITIVE EXAMS ✅JOB VACANCIES ✅MSPC & FDA , FOOD,DRUG LICENSE SERVICES ,JOB Please Msg only.. ✅PHARMA AWARENESS
Show more📈 Analytical overview of Telegram channel PHARMA SOLUTION
Channel PHARMA SOLUTION (@pharmasolutionindia) in the Marathi language segment is an active participant. Currently, the community unites 12 778 subscribers, ranking 2 060 in the Medicine category and 33 584 in the India region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 12 778 subscribers.
According to the latest data from 09 June, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 98 over the last 30 days and by 1 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 28.84%. Within the first 24 hours after publication, content typically collects 14.08% reactions from the total number of subscribers.
- Post reach: On average, each post receives 3 685 views. Within the first day, a publication typically gains 1 799 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 13.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“https://pharmasolutionsindia.in/
✍️A PROFESSIONAL PHARMA ONLINE SERVICE
✅ 🏆🏆 FOR PHARMACIST 🏆🏆
✅ PHARMA COMPETITIVE EXAMS
✅JOB VACANCIES
✅MSPC & FDA , FOOD,DRUG LICENSE SERVICES ,JOB Please Msg only..
✅PHARMA AWARENESS”
Thanks to the high frequency of updates (latest data received on 10 June, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Available now! Telegram Research 2025 — the year's key insights 
